1. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
- Author
-
Hsu, Po-Yao, Hsu, Cheng-Ting, Yeh, Ming-Lun, Huang, Chung-Feng, Huang, Ching-I, Liang, Po-Cheng, Lin, Yi-Hung, Hsieh, Ming-Yen, Wei, Yu-Ju, Hsieh, Meng-Hsuan, Dai, Chia-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Yu, Ming-Lung, and Chuang, Wan-Long
- Subjects
- *
HYPERTENSION epidemiology , *THERAPEUTIC use of antineoplastic agents , *OBESITY , *SURVIVAL , *RESEARCH , *LIVER tumors , *CHRONIC hepatitis C , *RESEARCH methodology , *CIRRHOSIS of the liver , *DIABETES , *PROGNOSIS , *CATHETER ablation , *CHEMOEMBOLIZATION , *EVALUATION research , *MEDICAL cooperation , *SERUM albumin , *TUMOR classification , *SEVERITY of illness index , *COMPARATIVE studies , *PLATELET count , *DISEASE prevalence , *RESEARCH funding , *RADIOTHERAPY , *LIVER transplantation , *HEPATOCELLULAR carcinoma , *ASPARTATE aminotransferase , *PROPORTIONAL hazards models , *ALANINE aminotransferase , *CHRONIC hepatitis B , *COMORBIDITY , *HEPATECTOMY , *DISEASE complications - Abstract
Background and Aims: The features of non-viral, nonalcohol hepatocellular carcinoma (NBNC-HCC) remain elusive. The aim of this study was to investigate this clinical characteristics and overall survival of NBNC-HCC compared to hepatitis B- (HBV-HCC) and hepatitis C-related (HCV-HCC) HCC.Methods: We analyzed the etiologies, fibrosis stages, clinical data, and outcomes of newly diagnosed patients with HCC.Results: A total of 1777 HCC patients were recruited, including 332 patients with NBNC-HCC, 682 patients with HBV-HCC, 680 patients with HCV-HCC, and 83 patients with HBV/HCV HCC. Patients with NBNC-HCC were older (69.9 ± 11.9 years). Patients with NBNC-HCC exhibited a higher prevalence of diabetes (43.9%) compared to the HBV-HCC (27.1%, p < 0.05) and HCV-HCC (30.2%, p < 0.05) groups. Compared to patients from the viral-related HCC groups, patients with NBNC-HCC exhibited a significantly lower fibrosis stage. NBNC-HCC patients exhibited a higher proportion of Barcelona Clinic Liver Cancer (BCLC) classification stage C and stage D compared to patients from the HBV-HCC and HCV-HCC groups. With a mean of 2.33 ± 2.31 years of follow-up, the median survival of patients with NBNC-HCC was 1.75 (95% CI 1.33-2.17) years, which was significantly lower than that of patients with HBV-HCC (p = 0.041) and HCV-HCC (p < 0.001).Conclusions: Patients with NBNC-HCC have a higher risk of diabetes than patients with HCC of viral etiologies. Although patients with NBNC-HCC exhibited a milder fibrosis stage, their more advanced HCC stages and worse overall survival should be taken into consideration in clinical care. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF